Role of NT-ProBNP in Differentiating Cardiac and Non-Cardiac Causes of Dyspnea in Patients Presenting to the Emergency Department of a Tertiary Care Teaching Hospital

Background: Dyspnea is a common presenting symptom in emergency departments (ED), with diverse etiologies ranging from cardiac to pulmonary causes.Rapid differentiation between cardiac and non-cardiac origins is crucial for appropriate management.This pilot study aimed to evaluate the diagnostic utility of N-terminal pro-brain natriuretic peptide (NT-proBNP) in distinguishing cardiac from non-cardiac causes of dyspnea in ED patients at a tertiary care teaching hospital.Methods: A prospective observational study was conducted over 3 months.Fifty adult patients presenting to the ED with acute dyspnea were enrolled.Clinical assessment, routine investigations, and NT-proBNP levels were measured upon admission.Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal NT-proBNP cutoff value.Results: Of the 50 enrolled patients (mean age 62.514.3years, 54% male), 28 (56%) were diagnosed with cardiac causes of dyspnea, while 22 (44%) had non-cardiac etiologies.The median NT-proBNP level was significantly higher in patients with cardiac causes (1,850 pg/mL, IQR: 980-3,200) compared to non-cardiac causes (210 pg/mL, IQR: 90-450, p<0.001).ROC curve analysis yielded an area under the curve of 0.89 (95% CI: 0.80-0.98).An NT-proBNP cutoff value of 800 pg/mL demonstrated a sensitivity of 82% and specificity of 86% for identifying cardiac causes of dyspnea.The positive and negative predictive values were 88% and 79%, respectively.Conclusion: NT-proBNP showed promising results as a biomarker for differentiating cardiac from non-cardiac causes of dyspnea in ED patients.

Authors

Publication Details

Journal
SSR Institute of International Journal of Life Sciences
Published
2025-09-01
DOI
https://doi.org/10.21276/ssr-iijls.2025.11.5.7
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of NT-ProBNP in Differentiating Cardiac and Non-Cardiac Causes of Dyspnea in Patients Presenting to the Emergency Department of a Tertiary Care Teaching Hospital

Rey J, S. Pereira, B Sudha
SSR Institute of International Journal of Life Sciences
Heart Failure Treatment and Management
article

Role of NT-ProBNP in Differentiating Cardiac and Non-Cardiac Causes of Dyspnea in Patients Presenting to the Emergency Department of a Tertiary Care Teaching Hospital

Rey J, S. Pereira, B Sudha
article en

Abstract

Background: Dyspnea is a common presenting symptom in emergency departments (ED), with diverse etiologies ranging from cardiac to pulmonary causes.Rapid differentiation between cardiac and non-cardiac origins is crucial for appropriate management.This pilot study aimed to evaluate the diagnostic utility of N-terminal pro-brain natriuretic peptide (NT-proBNP) in distinguishing cardiac from non-cardiac causes of dyspnea in ED patients at a tertiary care teaching hospital.Methods: A prospective observational study was conducted over 3 months.Fifty adult patients presenting to the ED with acute dyspnea were enrolled.Clinical assessment, routine investigations, and NT-proBNP levels were measured upon admission.Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal NT-proBNP cutoff value.Results: Of the 50 enrolled patients (mean age 62.514.3years, 54% male), 28 (56%) were diagnosed with cardiac causes of dyspnea, while 22 (44%) had non-cardiac etiologies.The median NT-proBNP level was significantly higher in patients with cardiac causes (1,850 pg/mL, IQR: 980-3,200) compared to non-cardiac causes (210 pg/mL, IQR: 90-450, p<0.001).ROC curve analysis yielded an area under the curve of 0.89 (95% CI: 0.80-0.98).An NT-proBNP cutoff value of 800 pg/mL demonstrated a sensitivity of 82% and specificity of 86% for identifying cardiac causes of dyspnea.The positive and negative predictive values were 88% and 79%, respectively.Conclusion: NT-proBNP showed promising results as a biomarker for differentiating cardiac from non-cardiac causes of dyspnea in ED patients.

SSR Institute of International Journal of Life SciencesVol. 11(5)
Openalex Percentile: Top 63%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.